Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""tirofiban"" wg kryterium: Temat


Tytuł :
Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke.
Autorzy :
Yang J; Department of Neurology (J.Y., Y.W.), Ningbo First Hospital, Zhejiang, China.
Wu Y; Department of Neurology (J.Y., Y.W.), Ningbo First Hospital, Zhejiang, China.
Gao X; Department of Neurosurgery (X.G.), Ningbo First Hospital, Zhejiang, China.
Bivard A; Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Australia (A.B., M.W.P.).
Levi CR; School of Medicine and Public Health, University of Newcastle, Australia (C.R.L., M.W.P., L.L.).
Parsons MW; Melbourne Brain Centre at Royal Melbourne Hospital, University of Melbourne, Australia (A.B., M.W.P.).; School of Medicine and Public Health, University of Newcastle, Australia (C.R.L., M.W.P., L.L.).
Lin L; School of Medicine and Public Health, University of Newcastle, Australia (C.R.L., M.W.P., L.L.).
Pokaż więcej
Corporate Authors :
INSPIRE Study Group†
Źródło :
Stroke [Stroke] 2020 Oct; Vol. 51 (10), pp. 2925-2933. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Endovascular Procedures*
Thrombectomy*
Brain Ischemia/*therapy
Fibrinolytic Agents/*therapeutic use
Stroke/*therapy
Tirofiban/*therapeutic use
Aged ; Brain Ischemia/drug therapy ; Brain Ischemia/surgery ; Combined Modality Therapy ; Female ; Fibrinolytic Agents/administration & dosage ; Humans ; Infusions, Intra-Arterial ; Infusions, Intravenous ; Male ; Middle Aged ; Registries ; Retrospective Studies ; Stroke/drug therapy ; Stroke/surgery ; Tirofiban/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
Autorzy :
Wang H; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Li X; Department of Neurology, The Third Affiliated Hospital of Army Medical University, Chongqing, China.
Liu C; Department of Neurology, The Third Affiliated Hospital of Army Medical University, Chongqing, China.
Huang S; Department of Neurology, The Third Affiliated Hospital of Army Medical University, Chongqing, China.
Liang C; Department of Neurology, The Third Affiliated Hospital of Army Medical University, Chongqing, China.
Zhang M; Department of Neurology, The Third Affiliated Hospital of Army Medical University, Chongqing, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Aug; Vol. 29 (8), pp. 104829. Date of Electronic Publication: 2020 May 21.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Brain Ischemia/*drug therapy
Platelet Aggregation Inhibitors/*administration & dosage
Stroke/*drug therapy
Tirofiban/*administration & dosage
Administration, Intravenous ; Administration, Oral ; Aged ; Brain Ischemia/diagnosis ; Brain Ischemia/mortality ; Brain Ischemia/physiopathology ; Disability Evaluation ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors ; Recovery of Function ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Stroke/physiopathology ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis.
Autorzy :
Huo X; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Yang M; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Ma N; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Gao F; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Mo D; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Li X; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Wang A; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Wang Y; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Miao Z; Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.; China National Clinical Research Center for Neurological Diseases, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Clinical interventions in aging [Clin Interv Aging] 2020 Jul 23; Vol. 15, pp. 1241-1248. Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Brain Ischemia/*therapy
Mechanical Thrombolysis/*adverse effects
Stroke/*therapy
Thrombolytic Therapy/*methods
Tirofiban/*therapeutic use
Administration, Intravenous ; Aged ; Aged, 80 and over ; Brain Ischemia/complications ; Female ; Humans ; Male ; Mechanical Thrombolysis/methods ; Middle Aged ; Stroke/complications ; Thrombectomy ; Thrombolytic Therapy/adverse effects ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Tirofiban for acute ischemic stroke: systematic review and meta-analysis.
Autorzy :
Gong J; Department of Pharmacy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.; Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou, China.
Shang J; Department of Pharmacy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
Yu H; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Wan Q; Department of Pharmacy, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
Su D; Department of Pharmacy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
Sun Z; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, Jiangsu, China. .
Liu G; Department of Pharmacy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China. .
Pokaż więcej
Źródło :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Apr; Vol. 76 (4), pp. 475-481. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Brain Ischemia/*drug therapy
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*drug therapy
Tirofiban/*therapeutic use
Brain Ischemia/complications ; Brain Ischemia/mortality ; Humans ; Injections, Intra-Arterial ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/mortality ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Stroke/etiology ; Stroke/mortality ; Tirofiban/administration & dosage ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention.
Autorzy :
Wang H; Department Pharmacy, the Second Clinical Hospital of Shanxi Medical University, Taiyuan, Shanxi.
Feng M; AstraZeneca (Wuxi) trading co. LTD, Wuxi, Jiangsu, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Jun 05; Vol. 99 (23), pp. e20402.
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention/*methods
ST Elevation Myocardial Infarction/*drug therapy
Tirofiban/*administration & dosage
Tirofiban/*standards
Aged ; Chi-Square Distribution ; Female ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/standards ; Percutaneous Coronary Intervention/statistics & numerical data ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/standards ; Platelet Aggregation Inhibitors/therapeutic use ; ST Elevation Myocardial Infarction/epidemiology ; Stroke Volume/drug effects ; Tirofiban/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
Autorzy :
Ma Q; Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China.
Ma Y; Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China.
Wang X; Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China.
Li S; Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China.
Yu T; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Duan W; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Wu J; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Wen Z; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Jiao Y; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Sun Z; Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Hou Y; Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning, People's Republic of China. .
Pokaż więcej
Źródło :
The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2020 Jun; Vol. 36 (6), pp. 1121-1132. Date of Electronic Publication: 2020 Feb 20.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Magnetic Resonance Imaging, Cine*
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Coronary Circulation/*drug effects
Microcirculation/*drug effects
Myocardial Reperfusion Injury/*prevention & control
Platelet Aggregation Inhibitors/*administration & dosage
ST Elevation Myocardial Infarction/*therapy
Tirofiban/*administration & dosage
Administration, Intravenous ; Adult ; China ; Female ; Humans ; Male ; Middle Aged ; Myocardial Reperfusion Injury/diagnostic imaging ; Myocardial Reperfusion Injury/mortality ; Myocardial Reperfusion Injury/physiopathology ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors ; Predictive Value of Tests ; Prospective Studies ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; ST Elevation Myocardial Infarction/physiopathology ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome ; Ventricular Function, Left/drug effects ; Ventricular Remodeling/drug effects
Czasopismo naukowe
Tytuł :
Myocardial reperfusion with tirofiban injection via aspiration catheter : Efficacy and safety in STEMI patients with large thrombus burden.
Autorzy :
Zhang Z; Department of Cardiology, Panyu Central Hospital (Cardiovascular Institute of Panyu District), 511400, Guangzhou, China.
Li W; Department of Cardiology, Ganzhou City People's Hospital, 341000, Ganzhou, China.
Wu W; Department of Cardiology, Panyu Central Hospital (Cardiovascular Institute of Panyu District), 511400, Guangzhou, China.
Xie Q; Department of Cardiology, Panyu Central Hospital (Cardiovascular Institute of Panyu District), 511400, Guangzhou, China.
Li J; Department of Cardiology, Panyu Central Hospital (Cardiovascular Institute of Panyu District), 511400, Guangzhou, China.
Zhang W; Department of Cardiology, Panyu Central Hospital (Cardiovascular Institute of Panyu District), 511400, Guangzhou, China.
Zhang Y; Department of Ultrasound, Guangdong Women and Children Hospital, No. 521 Xingnan Avenue, 511400, Guangzhou, China. .
Pokaż więcej
Transliterated Title :
Myokardreperfusion mit Tirofibaninjektion via Aspirationskatheter : Wirksamkeit und Sicherheit bei STEMI-Patienten mit hoher Thrombuslast.
Źródło :
Herz [Herz] 2020 May; Vol. 45 (3), pp. 280-287. Date of Electronic Publication: 2018 Jun 12.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Angioplasty, Balloon, Coronary*
Fibrinolytic Agents*/therapeutic use
Percutaneous Coronary Intervention*
ST Elevation Myocardial Infarction*/drug therapy
Thrombosis*/complications
Thrombosis*/drug therapy
Tirofiban*/therapeutic use
Humans ; Myocardial Reperfusion ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment.
Autorzy :
Yan Z; Department of Neurosurgery, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing Jiangsu Province, People's Republic of China; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Shi Z; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Wang Y; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Zhang C; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Cao J; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Ding C; Department of Neurosurgery, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Qu M; Department of Radiology, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Xia Y; Department of Radiology, The 904th Hospital of the Joint Logistics Support force of Chinese People's Liberation Army, Wuxi Jiangsu Province, People's Republic of China.
Cai J; Department of Neurosurgery, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing Jiangsu Province, People's Republic of China.
Zhang X; Department of Neurosurgery, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing Jiangsu Province, People's Republic of China. Electronic address: .
Wang H; Department of Neurosurgery, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing Jiangsu Province, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Apr; Vol. 29 (4), pp. 104619. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Endovascular Procedures*/adverse effects
Endovascular Procedures*/mortality
Brain Ischemia/*therapy
Intracranial Arteriosclerosis/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Stroke/*therapy
Tirofiban/*administration & dosage
Aged ; Aged, 80 and over ; Brain Ischemia/diagnosis ; Brain Ischemia/mortality ; Brain Ischemia/physiopathology ; Disability Evaluation ; Female ; Humans ; Intracranial Arteriosclerosis/diagnosis ; Intracranial Arteriosclerosis/mortality ; Intracranial Arteriosclerosis/physiopathology ; Male ; Middle Aged ; Plaque, Atherosclerotic ; Platelet Aggregation Inhibitors/adverse effects ; Recovery of Function ; Recurrence ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Stroke/physiopathology ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis.
Autorzy :
Corcione N; Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy.
Pepe M; U.O. di Cardiologia Universitaria, Policlinico di Bari, Bari, Italy. Electronic address: .
Ferraro P; Unità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano, Italy.
Morello A; Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy.
Conte S; Unità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano, Italy.
Avellino R; Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy; Unità Operativa di Emodinamica, Casa di Salute Santa Lucia, San Giuseppe Vesuviano, Italy.
Cavarretta E; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Napoli, Italy.
Carulli E; U.O. di Cardiologia Universitaria, Policlinico di Bari, Bari, Italy.
Biondi-Zoccai G; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Napoli, Italy.
Giordano A; Unità Operativa di Interventistica Cardiovascolare, Presidio Ospedaliero Pineta Grande, Castel Volturno, Italy.
Pokaż więcej
Źródło :
Annals of vascular surgery [Ann Vasc Surg] 2020 Apr; Vol. 64, pp. 151-156.e2. Date of Electronic Publication: 2019 Oct 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Stents*
Carotid Artery Diseases/*therapy
Endovascular Procedures/*instrumentation
Heart Diseases/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Tirofiban/*therapeutic use
Troponin/*blood
Aged ; Anticoagulants/therapeutic use ; Biomarkers/blood ; Carotid Artery Diseases/diagnostic imaging ; Databases, Factual ; Dual Anti-Platelet Therapy ; Endovascular Procedures/adverse effects ; Female ; Heart Diseases/blood ; Heart Diseases/diagnosis ; Heart Diseases/etiology ; Heparin/therapeutic use ; Humans ; Male ; Platelet Aggregation Inhibitors/adverse effects ; Propensity Score ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis.
Autorzy :
Wang W; Department of Emergency and Chest Pain Center, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Clinical Research Center for Emergency and Critical Care Medicine of Shandong Province, Institute of Emergency and Critical Care Medicine of Shandong University, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Cheeloo College of Medicine, Qilu Hospital of Shandong University.
Wang B; Clinical Trial Center, Cheeloo College of Medicine, Qilu Hospital of Shandong University.
Chen Y; Department of Emergency and Chest Pain Center, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Clinical Research Center for Emergency and Critical Care Medicine of Shandong Province, Institute of Emergency and Critical Care Medicine of Shandong University, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Cheeloo College of Medicine, Qilu Hospital of Shandong University.
Wei S; Department of Emergency and Chest Pain Center, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Clinical Research Center for Emergency and Critical Care Medicine of Shandong Province, Institute of Emergency and Critical Care Medicine of Shandong University, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Cheeloo College of Medicine, Qilu Hospital of Shandong University.; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Cheeloo College of Medicine, Qilu Hospital of Shandong University.
Pokaż więcej
Źródło :
International heart journal [Int Heart J] 2021 Jan 30; Vol. 62 (1), pp. 171-174. Date of Electronic Publication: 2021 Jan 16.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Coronary Occlusion/*etiology
Coronary Restenosis/*etiology
Myocardial Infarction/*diagnosis
Acute Disease ; Adult ; Aftercare ; Angioplasty, Balloon, Coronary/methods ; Aspirin/administration & dosage ; Aspirin/therapeutic use ; Clopidogrel/administration & dosage ; Clopidogrel/adverse effects ; Clopidogrel/therapeutic use ; Coronary Angiography/methods ; Coronary Occlusion/diagnostic imaging ; Coronary Restenosis/therapy ; Cytochrome P-450 CYP2C19/genetics ; Dual Anti-Platelet Therapy/adverse effects ; Dual Anti-Platelet Therapy/methods ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/therapeutic use ; Humans ; Integrin alpha2/genetics ; Mutation/genetics ; Myocardial Infarction/etiology ; Purinergic P2Y Receptor Antagonists/administration & dosage ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Stents/adverse effects ; Thrombectomy/methods ; Thrombosis/therapy ; Ticagrelor/administration & dosage ; Ticagrelor/therapeutic use ; Tirofiban/administration & dosage ; Tirofiban/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Near-infrared -triggered release of tirofiban from nanocarriers for the inhibition of platelet integrin αIIbβ3 to decrease early-stage neointima formation.
Autorzy :
Zhao Z; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Qiu P; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Lu H; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Yin M; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Liu X; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Li F; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Liu K; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. and Department of Vascular Surgery, Qingdao Municipal Hospital Affiliated to Qingdao University Medical College, Qingdao 266000, China.
Li D; Department of Vascular Surgery, Qingdao Municipal Hospital Affiliated to Qingdao University Medical College, Qingdao 266000, China.
Lu X; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Li B; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China. .
Pokaż więcej
Źródło :
Nanoscale [Nanoscale] 2020 Feb 20; Vol. 12 (7), pp. 4676-4685.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Carriers*/chemistry
Drug Carriers*/pharmacokinetics
Drug Carriers*/pharmacology
Infrared Rays*
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
Tirofiban*/chemistry
Tirofiban*/pharmacokinetics
Tirofiban*/pharmacology
Blood Platelets/*metabolism
Neointima/*drug therapy
Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors
Animals ; Blood Platelets/pathology ; Mice ; Mice, Knockout, ApoE ; Neointima/metabolism ; Neointima/pathology ; Platelet Glycoprotein GPIIb-IIIa Complex/metabolism ; RAW 264.7 Cells
Czasopismo naukowe
Tytuł :
Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis.
Autorzy :
Fu Z; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China, .
Xu C; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Liu X; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Wang Z; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Gao L; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Pokaż więcej
Źródło :
Cerebrovascular diseases (Basel, Switzerland) [Cerebrovasc Dis] 2020; Vol. 49 (4), pp. 442-450. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Brain Ischemia/*therapy
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*therapy
Tirofiban/*therapeutic use
Brain Ischemia/diagnosis ; Brain Ischemia/mortality ; Endovascular Procedures/adverse effects ; Endovascular Procedures/mortality ; Hemorrhage/chemically induced ; Humans ; Patient Safety ; Platelet Aggregation Inhibitors/adverse effects ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
Autorzy :
Fu B; Department of Neurology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Hubei University of Chinese Medicine, 430000, Wuhan, China. .
Chen Y; Department of Neurology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Hubei University of Chinese Medicine, 430000, Wuhan, China.
Li P; Department of Neurology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Hubei University of Chinese Medicine, 430000, Wuhan, China. .
Pokaż więcej
Źródło :
BMC neurology [BMC Neurol] 2021 Jan 05; Vol. 21 (1), pp. 4. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Brain Ischemia/*etiology
COVID-19/*complications
Ischemic Stroke/*etiology
Aspirin/therapeutic use ; Atorvastatin/therapeutic use ; Brain Ischemia/drug therapy ; Fibrinolytic Agents/therapeutic use ; Humans ; Ischemic Stroke/drug therapy ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2 ; Tirofiban/therapeutic use
Czasopismo naukowe
Tytuł :
In Reply: The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage.
Autorzy :
Zanaty M; Department of Neurosurgery University of Iowa Iowa City, Iowa.
Limaye K; Division of Cerebrovascular Diseases Department of Neurology University of Iowa Iowa City, Iowa.
Roa JA; Department of Neurosurgery University of Iowa Iowa City, Iowa.; Division of Cerebrovascular Diseases Department of Neurology University of Iowa Iowa City, Iowa.
Samaniego E; Department of Neurosurgery University of Iowa Iowa City, Iowa.; Division of Cerebrovascular Diseases Department of Neurology University of Iowa Iowa City, Iowa.; Department of Radiology University of Iowa Iowa City, Iowa.
Hasan D; Department of Neurosurgery University of Iowa Iowa City, Iowa.
Pokaż więcej
Źródło :
Neurosurgery [Neurosurgery] 2020 Mar 01; Vol. 86 (3), pp. E352.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Aneurysm, Ruptured*
Tirofiban*
Drainage ; Humans ; Longitudinal Studies ; Stents
Czasopismo naukowe
Tytuł :
Letter: The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage.
Autorzy :
Martinez-Perez R; Department of Neurological Sciences Wexner Medical Center The Ohio State University Columbus, Ohio.
Moscote-Salazar LR; Neurosurgeon-Critical Care Center for Biomedical Research (CIB) Faculty of Medicine - University of Cartagena Cartagena de Indias, Bolivar, Colombia.
Deora H; Department of Neurosurgery National Institute of Mental Health and Neurosciences Bangalore, India.
Agrawal A; Department of Neurosurgery Narayana Medical College and Hospital Nellore, India.
Pokaż więcej
Źródło :
Neurosurgery [Neurosurgery] 2020 Mar 01; Vol. 86 (3), pp. E351.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Aneurysm, Ruptured*
Tirofiban*
Drainage ; Humans ; Longitudinal Studies ; Stents
Czasopismo naukowe
Tytuł :
The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage.
Autorzy :
Limaye K; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa, Iowa City, Iowa.
Zanaty M; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.
Hudson J; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.
Nakagawa D; Department of Neurosurgery, University of Tokyo, Tokyo, Japan.
Al Kasab S; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa, Iowa City, Iowa.
Alvarez C; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.
Dandapat S; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa, Iowa City, Iowa.
Kung DK; Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Ortega-Gutierrez S; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa, Iowa City, Iowa.; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.; Department of Radiology, University of Iowa, Iowa City, Iowa.
Jabbour P; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
Samaniego EA; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa, Iowa City, Iowa.; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.; Department of Radiology, University of Iowa, Iowa City, Iowa.
Hasan D; Departmnet of Neurosurgery, University of Iowa, Iowa City, Iowa.
Pokaż więcej
Źródło :
Neurosurgery [Neurosurgery] 2019 Dec 01; Vol. 85 (6), pp. E1037-E1042.
Typ publikacji :
Journal Article
MeSH Terms :
Aneurysm, Ruptured*/drug therapy
Aneurysm, Ruptured*/etiology
Aneurysm, Ruptured*/surgery
Platelet Aggregation Inhibitors*/administration & dosage
Platelet Aggregation Inhibitors*/adverse effects
Platelet Aggregation Inhibitors*/therapeutic use
Tirofiban*/administration & dosage
Tirofiban*/adverse effects
Tirofiban*/therapeutic use
Subarachnoid Hemorrhage/*complications
Administration, Intravenous ; Drainage/methods ; Humans ; Retrospective Studies ; Stents ; Ventriculoperitoneal Shunt
Czasopismo naukowe
Tytuł :
Efficacy and safety of tirofiban therapy in patients receiving endovascular treatment after large vessel ischaemic stroke: A systematic review and meta-analysis.
Autorzy :
Zhang P; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China. Electronic address: .
Guo Y; Department of Internal Medicine, Characteristic Medical Center of Chinese People's Armed Police, Tianjin,China.
Shen J; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Li H; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Wang R; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Wang Y; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Yu X; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Yao Q; Department of Neurology, Beichen Traditional Chinese Medical Hospital, Tianjin, China.
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2020 Oct; Vol. 80, pp. 112-120. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Combined Modality Therapy/*methods
Endovascular Procedures/*methods
Fibrinolytic Agents/*therapeutic use
Intracranial Hemorrhages/*epidemiology
Ischemic Stroke/*drug therapy
Tirofiban/*therapeutic use
Aged ; Combined Modality Therapy/adverse effects ; Female ; Humans ; Intracranial Hemorrhages/etiology ; Ischemic Stroke/surgery ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.
Autorzy :
Ghonim AA; Department of Cardiovascular Medicine, Naser Institute for Research and Therapy, Cairo, Egypt.
Mostafa A; Cardiology Department, Menofia University, Almenofia Egypt.
Emara A; Cardiology Department, Menofia University, Almenofia Egypt.
Algazzar AS; Cardiology Department, Ahmed Maher Teaching Hospital, Cairo, Egypt. Email: .
Qutub MA; Division of Cardiology, Department of Medicine, King Abdulaziz University Hospital, Jeddah Saudi Arabia.
Pokaż więcej
Źródło :
Cardiovascular journal of Africa [Cardiovasc J Afr] 2019 Sep/Oct 23; Vol. 30 (5), pp. 285-289. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Diabetes Mellitus*/diagnosis
Diabetes Mellitus*/mortality
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Coronary Artery Disease/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
ST Elevation Myocardial Infarction/*therapy
Tirofiban/*administration & dosage
Administration, Intravenous ; Aged ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/mortality ; Coronary Artery Disease/physiopathology ; Coronary Circulation/drug effects ; Female ; Hemorrhage/chemically induced ; Hospital Mortality ; Humans ; Injections, Intra-Arterial ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Recovery of Function ; Recurrence ; Risk Factors ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; ST Elevation Myocardial Infarction/physiopathology ; Stroke Volume/drug effects ; Time Factors ; Tirofiban/adverse effects ; Treatment Outcome ; Ventricular Function, Left/drug effects
Czasopismo naukowe
Tytuł :
Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke.
Autorzy :
Pan X; Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zheng D; Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, Australia.; The George Institute for Global Health University of New South Wales, Sydney, NSW, Australia.
Zheng Y; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Chan PWL; Department of Pharmacology and Pharmacy The University of Hong Kong, Hong Kong, China.
Lin Y; Department of Neurology The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Zou J; Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Zhou J; Department of Neurology Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yang J; Department of Neurology The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Pokaż więcej
Źródło :
European journal of neurology [Eur J Neurol] 2019 Aug; Vol. 26 (8), pp. 1105-1110. Date of Electronic Publication: 2019 Mar 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Ischemia/*therapy
Endovascular Procedures/*methods
Fibrinolytic Agents/*therapeutic use
Stroke/*therapy
Tirofiban/*therapeutic use
Aged ; Aged, 80 and over ; Brain Ischemia/drug therapy ; Combined Modality Therapy ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries ; Stroke/drug therapy ; Thrombolytic Therapy ; Tirofiban/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Investigation of the in vitro effect of aspirin and tirofiban in children compared to adults.
Autorzy :
McCafferty C; Haematology Research Laboratory, Murdoch Children's Research Institute, Melbourne, Australia.
Busuttil-Crellin X; Haematology Research Laboratory, Murdoch Children's Research Institute, Melbourne, Australia.
Cowley J; Haematology Research Laboratory, Murdoch Children's Research Institute, Melbourne, Australia.
Linden M; School of Biomedical Sciences, The University of Western Australia, Perth, Australia.
Monagle P; Haematology Research Laboratory, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia; Department of Clinical Haematology, Royal Children's Hospital, Melbourne, Australia.
Ignjatovic V; Haematology Research Laboratory, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia. Electronic address: .
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2019 Sep; Vol. 181, pp. 67-70. Date of Electronic Publication: 2019 Jun 27.
Typ publikacji :
Letter
MeSH Terms :
Aspirin/*therapeutic use
Tirofiban/*therapeutic use
Adolescent ; Adult ; Aspirin/pharmacology ; Child ; Child, Preschool ; Female ; Humans ; Male ; Tirofiban/pharmacology ; Young Adult
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies